Flu vaccines: FDA approves AFLURIA® QUADRIVALENT from Seqirus

Seqirus announced this week that the US Food and Drug Administration (FDA) has approved AFLURIA(R) QUADRIVALENT (Influenza Vaccine) for use in persons 18 years of age and older. AFLURIA QUADRIVALENT is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. ["]